The drug or treatment is administered to a larger group (100 to 300).
Determine effectiveness.
Continue to evaluate safety.
Phase 3
This phase helps researchers gather additional information about the safety of the drug, confirm efficacy, and extend the effects in an even larger group and cohort. information so that the drug or treatment can be used safely.
Hundreds or even thousands (300-3000) of people may receive a new drug or treatment and be followed for several years.
Phase 4
Researchers gather additional safety information on an even larger group of people.
Gather data on long-term effectiveness and its effect on quality of life.
Evaluated by cost and against other similar drugs.
It receives FDA approval and is widely marketed.
Be The First To Know New Clinical Studies
Receive notifications via TEXT or EMAIL when new clinical trials are announced.